1. Market Research
  2. > Pathology Industry

Bladder Cancer Industry, June 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, Oncology, Biomarker, Clinical Trial, Drug.


 
1-10 of 24 reports for Bladder Cancer

Purchase Reports From Reputable Market Research Publishers

Bladder Cancer Treatment Drugs Markets in China

Bladder Cancer Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • June 2015
  • by Asia Market Information & Development Company

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Bladder Cancer Drug Pipeline Update 2015

Bladder Cancer Drug Pipeline Update 2015

  • $ 2 086
  • Industry report
  • June 2015
  • by Bioseeker

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate ...

 Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Non Muscle Invasive Bladder Cancer (NMIBC)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Non Muscle Invasive Bladder Cancer (NMIBC). ...

 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Non Muscle ...

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2015

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • April 2015
  • by Global Markets Direct

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladde ...

The 2016-2021 World Outlook for Bladder Cancer Therapeutics

The 2016-2021 World Outlook for Bladder Cancer Therapeutics

  • $ 995
  • Industry report
  • April 2015
  • by ICON Group

This econometric study covers the world outlook for bladder cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

Bladder Cancer-API Insights, 2015

Bladder Cancer-API Insights, 2015

  • $ 1 250
  • Industry report
  • April 2015
  • by Delve Insight

Summary DelveInsight’s, Bladder Cancer-API Insights, 2015,report provides Bladder Cancer drugs marketed details and API Manufacturers details across the globe along with the location. The report gives ...

Bladder Cancer Partnering 2010-2015

Bladder Cancer Partnering 2010-2015

  • $ 795
  • Industry report
  • March 2015
  • by Currentpartnering

The Bladder Cancer Partnering 2010-2015 report provides understanding and access to the bladder cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ...

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

  • $ 2 500
  • Industry report
  • February 2015
  • by Global Data

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015" ...

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight’s, “Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

About 1 700 reports for Bladder Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2014
    42 pages
  • Cancer  

    Oncology  

    Bladder Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.